The complexity of the human brain has made it difficult to study many brain disorders in model organisms, highlighting the need for an in vitro model of human brain development. Here we have developed a human pluripotent stem cell-derived three-dimensional organoid culture system, termed cerebral organoids, that develop various discrete, although interdependent, brain regions. These include a cerebral cortex containing progenitor populations that organize and produce mature cortical neuron subtypes. Furthermore, cerebral organoids are shown to recapitulate features of human cortical development, namely characteristic progenitor zone organization with abundant outer radial glial stem cells. Finally, we use RNA interference and patient-specific induced pluripotent stem cells to model microcephaly, a disorder that has been difficult to recapitulate in mice. We demonstrate premature neuronal differentiation in patient organoids, a defect that could help to explain the disease phenotype. Together, these data show that three-dimensional organoids can recapitulate development and disease even in this most complex human tissue.
The complexity of the human brain has made it difficult to study many brain disorders in model organisms, highlighting the need for an in vitro model of human brain development. Here we have developed a human pluripotent stem cell-derived three-dimensional organoid culture system, termed cerebral organoids, that develop various discrete, although interdependent, brain regions. These include a cerebral cortex containing progenitor populations that organize and produce mature cortical neuron subtypes. Furthermore, cerebral organoids are shown to recapitulate features of human cortical development, namely characteristic progenitor zone organization with abundant outer radial glial stem cells. Finally, we use RNA interference and patient-specific induced pluripotent stem cells to model microcephaly, a disorder that has been difficult to recapitulate in mice. We demonstrate premature neuronal differentiation in patient organoids, a defect that could help to explain the disease phenotype. Together, these data show that three-dimensional organoids can recapitulate development and disease even in this most complex human tissue.
Mammalian brain development begins with the expansion of the neuroepithelium to generate radial glial stem cells (RGs) 1 . These RGs divide at the apical surface within the ventricular zone (VZ) to generate neurons and intermediate progenitors. Intermediate progenitors populate the adjacent subventricular zone (SVZ), whereas neurons migrate through the intermediate zone to populate specific layers within the cortical plate. In humans, the organization of progenitor zones is markedly more elaborate; the SVZ is split by an inner fibre layer (IFL) into an inner SVZ and an outer SVZ (OSVZ) 2 . The OSVZ represents an entirely separate progenitor layer populated by intermediate progenitors and a unique stem cell subset termed outer radial glia (oRG) 3, 4 , which are only present to a limited degree in rodents 5 . Both the IFL and OSVZ are completely absent in mice 6 . These key differences allow for the striking expansion in neuronal output and brain size seen in humans 7, 8 .
Primary microcephaly is a neurodevelopmental disorder in which brain size is markedly reduced 9 . Autosomal-recessive mutations have been identified in several genes, all of which encode proteins localizing to the mitotic spindle apparatus 10 . Heretofore, primary microcephaly pathogenesis has primarily been examined in mouse models. However, mouse mutants for several of the known genes [11] [12] [13] [14] have failed to recapitulate the severely reduced brain size seen in human patients.
Given the dramatic differences between mice and humans, methods that recapitulate paradigms of human brain development in vitro have enormous potential. Although considerable progress has been made for in vitro models of whole-organ development for other systems-such as intestine 15 , pituitary 16 and retina 17, 18 -a three-dimensional culture model of the developing brain as a whole has not been established. Previous studies have modelled certain isolated neural tissues in vitro [19] [20] [21] [22] [23] , including dorsal cerebral cortical tissue, which could recapitulate many aspects of early development. However, later events such as the formation of discrete cortical layers with stereotypical inside-out organization as well as human characteristics, such as the presence of oRG cells and the unique organization of progenitor zones, were not described.
Here we describe a three-dimensional culture system for deriving brain tissue in vitro. These so-called cerebral organoids develop a variety of regional identities organized as discrete domains capable of influencing one another. Furthermore, cerebral cortical regions display an organization similar to the developing human brain at early stages, as well as the presence of a considerable oRG population. Moreover, cerebral cortical neurons mature to form various pyramidal identities with modest spatial separation. Finally, we use patient-derived induced pluripotent stem (iPS) cells and short hairpin RNA (shRNA) in these organoids to model CDK5RAP2-dependent pathogenesis of microcephaly, a disorder that has been difficult to model in mice.
Generation of cerebral organoids
Recent progress with in vitro models of various organ systems has demonstrated the enormous self-organizing capacity for pluripotent stem cells to form whole tissues 15, 18 . We built upon this concept and developed a protocol without the use of patterning growth factors, focusing instead on improving growth conditions and providing the environment necessary for intrinsic cues to influence development. We began with a modified approach to generate neuroectoderm from embryoid bodies 24 . Neuroectodermal tissues were then maintained in three-dimensional culture and embedded in droplets of Matrigel to provide a scaffold for more complex tissue growth. These Matrigel droplets were then transferred to a spinning bioreactor to enhance nutrient absorption (Fig. 1a ). This method led to rapid development of brain tissues, which we termed cerebral organoids, requiring only 8-10 days for the appearance of neural identity and 20-30 days for defined brain regions to form.
Cerebral organoids at early stages (15-20 days) formed large, continuous neuroepithelia surrounding a fluid-filled cavity reminiscent of a ventricle with characteristic apical localization of the neural specific N-cadherin ( Fig. 1b ). Furthermore, the neuroepithelium was larger and more continuous than tissues generated using a stationary approach 20 , which instead formed an aggregate of several small rosette-like neuroepithelia ( Fig. 1b and Extended Data Fig. 1a ).
Although tissues reached maximal size by 2 months, cerebral organoids formed large (up to 4 mm in diameter), complex heterogeneous tissues, which could survive indefinitely (currently up to 10 months) when maintained in a spinning bioreactor. Histological and gross morphological analysis revealed regions reminiscent of cerebral cortex, choroid plexus, retina and meninges ( Fig. 1c, d and Extended Data Fig. 1b ). Notably, tissues typically reached a size limit, probably because of the lack of a circulatory system and limitations in oxygen and nutrient exchange. Consistent with this, extensive cell death was visible in the core of these tissues (Extended Data Fig. 1c ), whereas the various brain regions developed along the exterior. Furthermore, cerebral organoids could be reproducibly generated with similar overall morphology and complexity from both human embryonic stem (ES) cells and iPS cells (Extended Data Fig. 1d, e ).
Cerebral organoids display discrete brain regions
Brain development in vivo exhibits a striking degree of heterogeneity and regionalization as well as interdependency of various brain regions. Histological analysis suggested that human cerebral organoids might similarly display heterogeneous brain regions. To examine this further, we first tested the efficiency of initial neural induction in these tissues by performing reverse transcriptase PCR (RT-PCR) for several markers of pluripotency and neural identity (Extended Data Fig. 2a ). As expected, pluripotency markers OCT4 (also known as POU5F1) and NANOG diminished during the course of organoid differentiation, whereas neural identity markers SOX1 and PAX6 were upregulated, indicating successful neural induction.
To test for early brain regionalization in whole organoids, we performed RT-PCR for forebrain (FOXG1 and SIX3) and hindbrain (KROX20 (also known as EGR2) and ISL1) markers ( Fig. 2a ), revealing the presence of both populations within the tissue. However, as tissue development proceeded, forebrain markers remained highly expressed whereas hindbrain markers decreased, reminiscent of the developmental expansion of forebrain tissue during human brain development 25 .
In order to test whether cells with these brain region identities developed as discrete regions within the organoids, as gross morphology would suggest, or were randomly interspersed within the tissue, we performed immunohistochemical staining for markers of forebrain, midbrain and hindbrain identities during early development of these tissues (16 days; Fig. 2b and Extended Data Fig. 2b ). PAX6 expression revealed several regions of forebrain identity, and OTX1 and OTX2 expression marked forebrain/midbrain identity. These regions were located adjacent to regions that lacked these markers but that were positive for hindbrain markers GBX2, KROX20 and PAX2, which was reminiscent of the early mid-hindbrain boundary, suggesting similar regional communication and probably mutual repression.
In vivo brain development involves increasing refinement of regional specification. Therefore, we examined further-developed cerebral organoid tissues for regional subspecification. We performed staining for the forebrain marker FOXG1 (Fig. 2c ), which labelled regions displaying typical cerebral cortical morphology. Many of these regions were also positive for EMX1 ( Fig. 2d ), indicating dorsal cortical identity. We also tested for further subregionalization by staining for cortical lobe markers, namely AUTS2, a marker of prefrontal cortex 26 (Fig. 2e ); TSHZ2, a marker of the occipital lobe 26 (Extended Data Fig. 2c ); and LMO4, a marker of frontal and occipital lobes but absent in parietal lobes 26 (Extended Data Fig. 2c ). These markers could be seen in neurons labelling distinct regions of dorsal cortex, suggesting subspecification of cortical lobes. 
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Furthermore, staining for markers of the hippocampus ( Fig. 2f ) and ventral forebrain ( Fig. 2g ) revealed specification of these regions, although they did not organize to form the overall structure seen in vivo. Notably, interneurons produced in ventral forebrain regions exhibited a morphology and location consistent with migration from ventral to dorsal tissues (Extended Data Fig. 2d ). Within the dorsal cortex, these neurons displayed neurites parallel to the apical surface, reminiscent of the migratory extensions seen in tangential migration in vivo ( Fig. 2h ). Notably, calretinin 1 interneurons were absent from the dorsal cortex of organoids lacking a ventral region (4 out of 4 NKX2-1-negative organoids), suggesting that interneurons originate in the ventral forebrain to migrate to the dorsal cortex. This suggests that distant regions can influence one another in developing cerebral organoids.
Finally, other brain structures could be observed, namely choroid plexus ( Fig. 2i ) and even immature retina ( Fig. 2j ). Overall, all tissues examined displayed regions with dorsal cortical morphology (35 out of 35; 100%), most displayed choroid plexus (25 out of 35; 71%) and several displayed ventral forebrain identity as determined by NKX2-1 immunoreactivity (12 out of 35; 34%), whereas only a few displayed retinal tissue (determined by presence of retinal pigmented epithelium; 4 out of 35; 11%). These results indicate that cerebral organoids developed a variety of brain region identities organized into discrete, although interdependent, domains.
Recapitulation of dorsal cortical organization
The most dramatic changes in brain evolution from rodent to human affect the dorsal cortex. Therefore, we analysed the organization of dorsal cortical regions within cerebral organoids. Staining for markers of RGs and newborn neurons ( Fig. 3a) revealed typical organization into a layer reminiscent of the VZ with neurons located at the basal surface. Staining for TBR1 ( Fig. 3b ) revealed proper development of neural identity and radial migration to the developing preplate (precursor to the cortical plate). Furthermore, staining for neural progenitor and neural-specific BAF (mammalian SWI/SNF chromatin-remodelling complex) components revealed the characteristic switch in chromatinremodelling complexes during neural fate specification 27, 28 (Extended Data Fig. 3a ). Finally, staining for the intermediate progenitor marker TBR2 (also known as EOMES) ( Fig. 3c ) revealed the presence of intermediate progenitors adjacent to the VZ. Thus, dorsal cortical tissues displayed typical progenitor zone organization.
In both mice and humans, cortical progenitors undergo a stereotypical nuclear movement called interkinetic nuclear migration (IKNM). Mitotic divisions occur at the apical surface of the VZ whereas the nuclei of cells in S phase are located on the basal side of the VZ 29 . We stained for the mitotic marker phospho-histone H3 ( Fig. 3d ) and observed most of the cells dividing at the apical surface. Similar observations were evident when we stained for phospho-vimentin (p-vimentin, Fig. 3e ), a marker of mitotic RGs. In addition, as this marker labels the entire cell, we could observe basal cellular processes typical of RGs, which extended to the outer surface of these tissues (Extended Data Fig. 3b ). Thus, RGs of cerebral organoids exhibited typical behaviour and morphological features.
To examine this in more detail, we used a method to label individual RGs for morphology and live imaging experiments. In the mouse brain, individual cells can be labelled by in utero electroporation of fluorescent-protein-expressing plasmids. Similarly, we injected green fluorescent protein (GFP) plasmid into fluid-filled cavities of cerebral organoids and electroporated RGs adjacent to these ventricle-like cavities (Extended Data Fig. 3c ). This approach led to reproducible expression of GFP in RGs, revealing typical morphology at various stages of development: early pseudostratified neuroepithelium (Extended Data Fig. 3d ) followed by later bipolar morphology with extended apical and basal processes (Extended Data Fig. 3e , f).
To test for IKNM, we performed live imaging of GFP-electroporated RGs in cerebral organoids and observed many examples of RGs that displayed movement of the cell body along the apical and basal processes ( Fig. 3f and Supplementary Video 1). Furthermore, we performed pulsechase experiments with the S-phase marker BrdU ( Fig. 3g ) and could observe a shift in RG nuclei from outer VZ localization towards the apical surface with time ( Fig. 3g ).
RGs in the VZ of rodents exhibit biased spindle orientation, predominantly horizontal, parallel to the ventricular surface [30] [31] [32] [33] . To examine whether RGs in human cerebral organoids exhibited a similar orientation bias, we used p-vimentin staining to examine the plane of division in mitotic RGs (Extended Data Fig. 3g ). We observed mainly horizontal orientations (41%) ( Fig. 3h ), somewhat similar to the orientation bias observed in other mammals. However, we also observed abundant oblique (37%) and vertical (22%) orientations, which were more abundant in these human tissues than has been described for rodent neocortex 30, 31, 34, 35 . Interestingly, these measurements reflected the same trend recently described in the human brain 36 , suggesting that the cerebral organoids could recapitulate aspects of human cortical development.
We examined further the fate potential of these divisions to test whether organoid RGs could divide symmetrically and/or asymmetrically. We 
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performed electroporation of GFP followed by a short 1-h BrdU pulse and a 16-h chase to lineage trace divisions of a small minority of cells. We examined double-labelled daughter-cell pairs and could observe both symmetric proliferative fate outcomes, as well as asymmetric outcomes ( Fig. 3i ). This suggests that the RGs in these human tissues can undergo both symmetric and asymmetric divisions.
Formation of functional cerebral cortical neurons
The formation of the radially organized cortical plate begins with the formation of its precursor, the preplate. To test for this initial organization, we stained 30-day organoids for TBR1, a marker of the preplate 37 , as well as MAP2, a neuronal marker 38 (Fig. 4a ). This revealed the presence of a basal neural layer reminiscent of the preplate, and an apically adjacent region reminiscent of the intermediate zone. Furthermore, we could observe reelin 1 neurons along the basal surface, suggesting the presence of Cajal-Retzius cells, a cell population important in the generation of cortical plate architecture 39 .
The stereotypical layered structure of the mammalian cortical plate is generated inside-out with later-born neurons migrating through existing layers to populate more superficial layers 40 . Although previous methods of deriving cortical neurons have been able to generate distinct layer identities 20, 23, 41 , they have been unable to recapitulate this spatial separation. To test whether this organization could be recapitulated in cerebral organoids, we stained for cortical layer markers. In less-developed tissues (30 day), early-born CTIP2 (also known as BCL11B) 1 neurons were located adjacent and internal to the TBR1 1 preplate, suggesting initiation of cortical plate layer formation (Extended Data Fig. 4a ). Furthermore, neurons exhibited rudimentary separation into an earlyborn deep layer (CTIP2 1 ) and a late-born superficial layer (SATB2 1 and BRN2 (also known as POU3F2) 1 ) (Extended Data Fig. 4b ), which became more distinct as tissues developed (75 days) ( Fig. 4c ). Finally, a cell-poor region reminiscent of the marginal zone was also evident (Extended Data Fig. 1b ). Notably, although this modest spatial separation was an improvement upon other in vitro methods, organoids could not recapitulate the same degree of mature layer organization as in vivo, suggesting that further cues are needed to generate the complex stereotypical layer II-VI organization.
In vivo, dorsal cortical neurons mature and extend long-range axons 42 . To test for these characteristics, we performed GFP electroporation and examined neuronal morphology. GFP-labelled axon projections displayed complex branching and growth cone behaviour (Extended Data Fig. 4c ) and projected long-range axons in a manner reminiscent of axon bundling (Extended Data Fig. 4d ) 43 .
Finally, we tested whether neurons within cerebral organoids could exhibit neural activity by performing calcium dye imaging to detect Ca 21 oscillations 44 , which revealed spontaneous calcium surges in individual cells ( Fig. 4d , Extended Data Fig. 4e and Supplementary Videos 2, 3). Furthermore, we applied exogenous glutamate ( Fig. 4e ) and observed more frequent calcium spikes, indicating glutamatergic receptor activity. Finally, we performed action potential blockade by application of tetrodotoxin and observed dampened calcium surges, indicating that calcium spikes were dependent upon neuronal activity ( Fig. 4f ).
Recapitulation of human cortical organization
Human brain development exhibits unique progenitor zone organization 2,7 .
To test whether features of human brain development were recapitulated in cerebral organoids, we examined the distribution of SOX2 1 progenitors and observed a population displaced from the apical surface ( Fig. 5a and Extended Data Fig. 5a ), consistent with an oRG identity. Furthermore, these fairly abundant oRGs appeared separated from the apical VZ by a TUJ1 1 fibre layer ( Fig. 5a ) reminiscent of the IFL. This organization suggests that human cerebral organoids could recapitulate at least some aspects of human cortical development.
To rule out the possibility that this OSVZ-like organization was an in vitro artefact, we adapted the method to mouse ES cells to generate mouse cerebral organoids and examined whether a similar organization was present (Extended Data Fig. 5b, c) . We observed much smaller cortical tissues in mouse organoids compared with humans, and only occasional oRGs that did not accumulate in an OSVZ-like region. These results indicate that OSVZ-and IFL-like layers are specific to human organoids.
We performed p-vimentin staining to examine the morphology of human oRGs, which revealed basal processes but a lack of apical processes (Fig. 5b) , a hallmark of oRGs 3, 4 . This suggests that these basally displaced SOX2 1 and p-vimentin 1 progenitors indeed represent human oRGs. We also examined the division mode of oRGs and could identify daughter cell pairs in which only one daughter cell maintained SOX2 expression ( Fig. 5c ), suggesting asymmetric division. Furthermore, we measured spindle orientation and found that nearly all oRGs divided vertically (Fig. 5d ). This division mode is remarkably similar to the findings recently described in human brain slice cultures 36 , suggesting recapitulation of human oRG behaviour in cerebral organoids.
Cerebral organoids model human microcephaly
Because disorders affecting human brain development have often proved difficult to recapitulate in animal models, we tested whether organoids could be used to model neurodevelopmental disorders. We identified a patient with severe microcephaly (213.2 s.d. below mean for age and sex, Fig. 6a ) and reduced stature (26.7 s.d., Supplementary Text and 
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Extended Data Fig. 6a ), who, as determined through exome sequencing and confirmed by capillary sequencing (Fig. 6b ), had compound heterozygous truncating mutations in CDK5RAP2. Skin fibroblasts from this patient revealed a loss of the CDK5RAP2 protein ( Fig. 6c and Extended Data Fig. 6b ) suggesting loss of function, consistent with previously reported CDK5RAP2 mutations in primary microcephaly patients 45, 46 .
We performed reprogramming of patient skin fibroblasts using lentiviral delivery of the four well-described reprogramming factors: OCT4, SOX2, MYC and KLF4 (refs 47, 48) . We generated many independent clones of iPS cells and characterized four of these for morphology and pluripotency. All four lines exhibited similar doubling times and colony morphology that was indistinguishable from control iPS cells (Extended Data Fig. 7a ). All lines could form embryoid bodies and stained positive for the pluripotency marker alkaline phosphatase (Extended Data Fig. 7b ).
We performed cerebral organoid culture from all four lines and observed smaller embryoid bodies, which when transferred to neural induction failed to develop further (Extended Data Fig. 7c ). We proposed that because the patient also displayed reduced stature, perhaps overall embryoid body growth was perturbed. Therefore, in order to allow the embryoid bodies to develop to a comparable size as control, we modified the protocol slightly by increasing the initial iPS cell number. This modification allowed for the formation of neuroectoderm and subsequent neural tissue for analysis, which revealed smaller neuroepithelial tissues and a large degree of neuronal outgrowth compared with control tissues (Fig. 6d and Extended Data Fig. 7d ). Immunohistochemical staining for progenitors and neurons revealed smaller neural tissues with only very few progenitor regions (Fig. 6e ). These overall smaller neural tissues were reminiscent of the reduced brain size seen in the patient.
These patient-derived cerebral organoids provided a unique opportunity to examine the cause of the hypoplasia seen in microcephaly. We therefore examined an earlier stage (22 days) and observed that, whereas control tissues displayed abundant, large neuroepithelial tissues composed of progenitors, patient-derived tissues displayed only occasional neuroepithelial regions (Extended Data Fig. 7e ). Furthermore, these tissues displayed decreased RGs and increased neurons compared with control ( Fig. 6f and Extended Data Fig. 7f ), suggesting premature neural 
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differentiation. To test this possibility, we performed BrdU pulse-chase experiments (Fig. 6g ), which revealed a marked increase in the number of BrdU 1 /doublecortin (DCX) 1 cells in patient organoids, consistent with premature neurogenic non-proliferative divisions. We next examined radial glial spindle orientation and observed that, whereas control tissues at this early stage (22 days) displayed exclusively horizontal orientations (Fig. 6h ), patient organoids displayed many oblique and vertical oriented spindles (Fig. 6h) . These results could explain the patient tissue phenotype because precise horizontal orientation of the spindle is necessary for early symmetric expansion of neural stem cells 32 .
Finally, we tested whether the phenotype could be rescued by reintroducing CDK5RAP2 protein. We performed co-electroporation of GFP and CDK5RAP2 into day-12 patient organoids and examined 6 days later. Because high overexpression of CDK5RAP2 was toxic (data not shown), the cells with high GFP signal did not survive to this time point. However, we could observe regions in CDK5RAP2-electroporated tissues with larger neuroepithelium compared with tissues electroporated only with GFP (Extended Data Fig. 7g ). This effect could be due to surviving cells with a low level of CDK5RAP2 re-expression. Supporting this interpretation, staining for GFP (Extended Data Fig. 7h ) revealed many lowlevel GFP 1 cells in CDK5RAP2-co-electroporated patient organoids with radial glial morphology (54% 6 2 s.e.m.; n 5 74 cells from three tissues). By contrast, GFP 1 cells in patient organoids electroporated with GFP alone exhibited mainly neuronal morphology with significantly fewer RG (19% 6 11 s.e.m.; n 5 102 cells from three tissues; P , 0.05, Student's t-test). Thus, we conclude that the phenotype is specific to the loss of CDK5RAP2.
As a further independent approach, we performed RNAi knockdown of CDK5RAP2 by co-electroporating GFP with two independent shRNAs found to knock down endogenous CDK5RAP2 (Extended Data Fig. 8a ). Both shRNAs led to a considerable loss of SOX2 1 progenitors and an increase in DCX 1 neurons ( Fig. 6i and Extended Data Fig. 8b) , reflecting a statistically significant increase in neuron production rather than progenitor maintenance (Extended Data Fig. 8c ). These findings support the conclusion that loss of CDK5RAP2 leads to premature neural differentiation at the expense of progenitors.
Discussion
We have established a novel approach to studying human neurodevelopmental processes through in vitro culture of cerebral organoids from human pluripotent stem cells. This method recapitulates not only fundamental mechanisms of mammalian neurodevelopment, but also displays characteristics of human brain development. We are hopeful that this method will allow for the study of a variety of neurodevelopmental processes specific to human brain development.
Furthermore, a primary goal in neuroscience is to understand the roots of human neurological disease. We have modelled at least some aspects of microcephaly in these cerebral organoids. The finding that progenitor zones in patient-derived tissues display premature neural differentiation at the expense of early progenitors supports a model in which the founder population of RG progenitors fails to properly expand in patient tissues, thereby leading to an overall smaller brain. This may also explain why mouse models have been unable to recapitulate the severity of the disorder in humans. It is proposed that the mouse founder population of neural progenitors do not undergo expansion to the same extent as in humans before the onset of neurogenesis 7 . Thus, a disruption of the founder population in mice would not lead to as severe an effect as that seen in humans. Overall, our findings suggest that we can use this in vitro culture system to model aspects of human neurodevelopment and neurological disease and hopefully provide novel insight into the pathogenesis of these disorders.
METHODS SUMMARY
For cerebral organoid differentiation, pluripotent stem cells were dissociated from mouse embryonic fibroblasts by dispase treatment followed by trypsinization to generate single cells. In total, 4,500 cells were plated in each well of an ultra-low binding 96-well plate (Corning) in human ES media with low concentration basic fibroblast growth factor (4 ng ml 21 ) and 50 mM Rho-associated protein kinase (ROCK) inhibitor 49 (Calbiochem) . Embryoid bodies were fed every other day for 6 days then transferred to low-adhesion 24-well plates (Corning) in neural induction media containing Dulbecco's modified eagle medium (DMEM)/F12, 1:100 N2 supplement (Invitrogen), Glutamax (Invitrogen), minimum essential medianonessential amino acids (MEM-NEAA) and 1 mg ml 21 heparin 50 (Sigma). The neuroepithelial tissues were fed every other day for 5 days. On day 11, tissues were transferred to droplets of Matrigel (BD Biosciences) by pipetting into cold Matrigel on a sheet of Parafilm with small 3 mm dimples. These droplets were allowed to gel at 37 uC, removed from the Parafilm and grown in differentiation media containing a 1:1 mixture of DMEM/F12 and Neurobasal containing 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement without vitamin A (Invitrogen), 3.5 ml l 21 2mercaptoethanol, 1:4,000 insulin (Sigma), 1:100 Glutamax (Invitrogen), 1:200 MEM-NEAA. After 4 days of stationary growth, the droplets were transferred to a spinning bioreactor containing differentiation media as above, except B27 supplement with vitamin A (Invitrogen) was used.
METHODS
Plasmid constructs and materials. GFP plasmid used for co-electroporation with shRNA and for live imaging was pCAG-GFP (Addgene plasmid 11150) 51 . shRNAs targeting human CDK5RAP2 were cloned using pSuper shRNA expression strategy (OligoEngine). Targeting sequences were as follows: shRNA 1, 59-AGGA CGTGTTGCTTCAGAAAT-39; shRNA 2, 59-AGAGTCAGCCTTCTGCTAAAG-39; shRNA 3, 59-GTGGAAGATCTCCTAACTAAA-39; shRNA 4, 59-ACTATGAGA CTGCTCTATCAG-39. The CDK5RAP2 expression construct was generated using the Gateway system (Invitrogen) by PCR amplification of CDK5RAP2 from MGC human CDK5RAP2 cDNA (clone ID: 9052276) using the primers with AttB sites: forward, 59-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGATGGACT TGGTGTTGGAAGA-39; reverse, 59-GGGGACCACTTTGTACAAGAAAGCTG GGTCAGCTTTATTGGCTGAAAGTTCTTCTC-39. CDK5RAP2 was cloned into destination vector pcDNA3.1/nV5-DEST. Cerebral organoid culture conditions. Human H9 ES (WA09) cells were obtained from WiCell at passage 26 with verified normal karyotype and contamination-free. iPS cells were obtained from System Biosciences (SC101A-1) verified pluripotent and contamination-free. All human pluripotent stem cell lines were regularly checked and confirmed negative for mycoplasma. Pluripotent stem cells were maintained on CF-1-gamma-irradiated mouse embryonic stem cells (MEFs) (Global Stem) according to WiCell protocols. On day 0 of organoid culture, ES cells or iPS cells at less than passage 50 were dissociated from MEFs by dispase treatment and MEFs were removed by gravity separation of stem cell colonies from MEFs before trypsinization of stem cells to generate single cells. In total, 4,500 cells were then plated in each well of an ultra-low-binding 96-well plate (Corning) in human ES media with low concentration basic fibroblast growth factor (4 ng ml 21 ) and 50 mM Rhoassociated protein kinase (ROCK) inhibitor 49 (Calbiochem).
Embryoid bodies were fed every other day for 6 days then transferred to lowadhesion 24-well plates (Corning) in neural induction media containing Dulbecco's modified eagle medium (DMEM)/F12, 1:100 N2 supplement (Invitrogen), Glutamax (Invitrogen), minimum essential media-nonessential amino acids (MEM-NEAA) and 1 mg ml 21 heparin 50 (Sigma). These began forming neuroepithelial tissues, which were fed every other day for 5 days. On day 11 of the protocol, tissues were transferred to droplets of Matrigel (BD Biosciences) by pipetting into cold Matrigel on a sheet of Parafilm with small 3 mm dimples. These droplets were allowed to gel at 37 uC and were subsequently removed from the Parafilm and grown in differentiation media containing a 1:1 mixture of DMEM/F12 and Neurobasal containing 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement without vitamin A (Invitrogen), 3.5 ml l 21 2-mercaptoethanol, 1:4,000 insulin (Sigma), 1:100 Glutamax (Invitrogen) and 1:200 MEM-NEAA.
After 4 days of stationary growth, the tissue droplets were transferred to a spinning bioreactor containing differentiation media as above except B27 supplement with vitamin A (Invitrogen) was used. Because retinoic acid has been shown to be important for neuronal differentiation in vivo 52 , we included it in the final media used to differentiate the cerebral organoids. Mouse organoid culture conditions. Mouse A9 ES cells were cultured on mitomycin-C-growth-inactivated MEFs and passaged according to standard protocols 53 . For the generation of mouse organoids, the organoid protocol was applied with the following modifications: cells were trypsinized and 2,000 stem cells were plated in each well of an ultra-low-binding 96-well plate in differentiation medium as described in ref. 20 (medium containing 10 mM SB431542 but without DKK1). Subsequent steps were followed according to the human organoid method using identical media compositions, with the exception that for mouse tissues faster timing was used according to morphology. Embryoid bodies were transferred to neural induction medium on day 4, embedded in Matrigel droplets on day 6, and on day 9 transferred to the spinning bioreactor. Organoid electroporation. Electroporation was performed using a Petri dish tissue electrode and electro-square-porator (ECM 830), both from BTX Harvard Apparatus. A total of 3 ml of 2 mg ml 21 total plasmid (GFP for live imaging, 1.8 mg ml 21 shRNA plus 0.2 mg ml 21 GFP for shRNA experiments) was injected in 4-5 locations within the organoid and electroporation was performed in differentiation media without antibiotics at 5 pulses, 80 V, 50-ms duration, 1-s interval. For rescue experiments, GFP expression plasmid and the CDK5RAP2 construct were coelectroporated at equal concentrations (1 mg ml 21 each). Live imaging in organoids. Live imaging was performed using a LSM780 confocal laser scanning system (Zeiss) equipped with temperature and CO 2 control. For calcium imaging, Fluo-4 direct (Life Technologies) was prepared according to manufacturer and applied 60 min before the start of imaging. Imaging was performed at 494 nm excitation and 516 nm emission, with frames taken every 20 s for 100 frames. Data analysis of calcium imaging was performed using ImageJ (Fiji). ROIs were manually selected and mean fluorescence was calculated for each time frame. Change in fluorescence was calculated as follows: DF/F 5 (F2F basal) )/ F background , in which F basal was the lowest mean fluorescence value across imaging and F background was the average mean fluorescence across all frames. Glutamate was added by bath application to media during imaging at a final concentration 100 mM. TTX was added by bath application to media during imaging at a final concentration of 1 mM and imaging was resumed after a 10-min incubation time. Histology and immunofluorescence. Tissues were fixed in 4% paraformaldehyde for 20 min at 4 uC followed by washing in PBS three times for 10 min. Tissues were allowed to sink in 30% sucrose overnight and then embedded in 10%/7.5% gelatin/ sucrose and cryosectioned at 20 mm. Tissue sections were stained with haematoxylin and eosin or used for immunostaining. For immunohistochemistry, sections were blocked and permeabilized in 0.25% Triton X-100 and 4% normal donkey serum in PBS. Sections were then incubated with primary antibodies in 0.1% Triton X-100, 4% normal donkey serum at the following dilutions: N-cadherin (mouse, BD Biosciences 610920, 1:500), SOX2 (rabbit, Chemicon, AB5603, 1:300),
Research subject and gene identification. Genomic DNA was extracted from peripheral blood of patient 3842 and the patient's parents by standard methods. Informed consent was obtained from the family and the study approved by the Multi-centre Research Ethics Committee for Scotland (04:MRE00/19). Wholeexome capture and sequencing was performed at the Wellcome Trust Sanger Institute, UK. DNA was sheared to 150-base-pair lengths by sonification (Covaris) before whole-exome capture and amplification using the SureSelect Human All Exon 50Mb kit (Agilent). Fragments were sequenced using the Illumina Hiseq platform. 76-base-pair paired-end sequence reads were aligned to the UCSC genome browser hg19 reference sequence using BWA. Sequence variants were obtained using GenomeAnalysisTK (http://www.broadinstitute.org/gatk/) and annotated with transcript and protein consequence, polyphen, condel and SIFT scores. Mutations were confirmed by bi-directional sequencing of PCR products using dye terminator chemistry on an ABI 3730 capillary sequencer (Applied Biosystems). Patient iPS cell reprogramming. Patient skin fibroblasts were reprogrammed using lentiviral delivery of OCT4, SOX2, KLF4 and MYC. Lentivirus production: a DNA mix consisting of virus packaging vectors (tat, rev, gag/pol, 1.5 mg each, and vsv-g, 3 mg) and the loxP-flanked OKSM reprogramming vector (OCT4, KLF4, SOX2, MYC, 30 mg) were transfected into 293 cells. In brief, 112.5 ml Fugene6 was added dropwise to 2 ml DMEM under constant vortexing followed by a 10-min incubation at room temperature (22 uC) . The DNA mix was added to the DMEM/ Fugene6 mix while vortexing to generate the final transfection mix. After a 15-min incubation at room temperature, the transfection mix was added onto 80% confluent 293 cells, cultured in 13 ml 293 culture medium. Virus-containing medium was collected and replaced with fresh medium 48, 60 and 72 h after transfection. The viral supernatant was stored at 4 uC. Reprogramming of human dermal fibroblasts: 1 3 10 5 dermal fibroblasts were seeded the day before infection onto 10-cm and 6-cm 0.1% gelatin-coated culture dishes. Cells were incubated for 12 h with viral supernatant 1:1 mixed with dermal fibroblast medium supplemented with 4 mg ml 21 polybrene. Thereafter, cells were washed with 1 3 PBS and cultured for 2 more days in dermal fibroblast medium. After 2 days medium was switched to human iPS cell medium supplemented with 10 ng ml 21 basic fibroblast growth factor (peprotech, cat. no. 100-18B), 10 mM CHIR99021 (stemgent, cat. no. 04-0004) and 1 mM PD 0325901 (stemgent, cat. no. 04-0006) and cells cultured for 21 days. Medium was changed every day. Outgrowing colonies, identified by morphological appearance, were picked and passaged on inactivated CF-1 MEFs (global stem, cat. no. GSC-6201M). Patient-derived iPS lines were compared to control iPS cells obtained from a healthy donor (System Biosciences, SC101A-1). Alkaline phosphatase staining was performed using Vector Blue Alkaline Phosphatase Substrate Kit (Vector Laboratories, SK5300). Quantifications in patient and control iPS-cell-derived organoids were performed blinded using coded file names in ImageJ. Fig. 5a revealing the presence of a separated region of oRGs (demarcated by arrowheads) that appear separate from the VZ in all regions (brackets) but more separated and with a layer of TUJ1 1 fibres in between in thicker parts of the cortical tissue (larger bracket). The entire organoid can be seen in Fig. 1c . b, Low-magnification image of a cerebral organoid derived from mouse ES cells stained for neurons (Tuj1, green) and neural progenitors (Sox2, red) revealing overall smaller organoid size as well as smaller cortical regions (arrows) than in humans. c, Higher magnification of a region of cortical identity in mouse cerebral organoids stained for RG progenitors (Sox2, red) revealing the presence of only a few oRGs (arrowheads) that do not organize into a separate layer such as that seen in humans. 
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